News

A Remarkable Win at the 8th Secret Light Awards   On June 4, 2025, Vivolight Medical won the Cutting-Edge Innovation Award at the 8th Secret Light Awards (SLA) held at Hilton Shenzhen World Exhibition & Convention Center. Its 355 nm cold-laser plaque-ablation system was chosen from among 20...

EuroPCR 2025 concluded with a wave of technological breakthroughs, and Vivolight Medical stood at the forefront with its revolutionary P80 Multimodal Cardiovascular OCT System. As the world’s first FDA-cleared OCT platform featuring integrated AI diagnosis, the P80 attracted global i...

April 11, 2025, Vivolight Medical announced that its independently developed Optical Coherence Tomography (OCT) system has obtained FDA 510(k) clearance. This milestone not only enbale the U.S. market entry, but also streamlines regulatory pathways across 20+ countries recog...

Optical Coherence Tomography (OCT) is revolutionizing modern cardiovascular interventions by providing high-resolution imaging for precise diagnosis and treatment. Recently, RSUD Al-Ihsan Hospital in Bandung, Indonesia, successfully performed two complex coronary interventions utilizing Vivolight OC...

Vivolight Medical’s at Arab Health 2025: Illuminating a New Era of Global Cooperation in the Year of the Snake   From January 27 to January 30, 2025, Vivolight Medical made a dazzling appearance at the global medical technology event—Arab Health 2025, showcasing China&rsqu...

Azerbaijan recently completed its First PCI Case Guided by Vivolight’s Multimodal P80 OCT (Optical Coherence Tomography) system, marking a groundbreaking achievement in the region’s cardiovascular care. Led by Dr. Ulvi, a renowned cardiologist, this milestone highlights Vi...

The LX Congreso Chileno de Cardiología y Cirugía Cardiovascular represents a distinguished academic forum, convening preeminent physicians from across the globe. This esteemed conference serves as a pivotal platform for the dissemination of the latest advancements in cardiology, a...

At the ISICAM academic conference in Indonesia, Vivolight Medical's flagship Optical Coherence Tomography (OCT) product, the Vivolight Medical's OCT Imaging System - Cornaris P80, made a grand appearance, capturing the attention of numerous practitioners.   About the ISICAM Confe...

On November 6, 2024, at the China International Import Expo in Shanghai, Siemens and Vivolight Medical jointly launched the world’s first DSA-OCT integrated multimodal diagnostic and therapeutic platform, the ARTIS icono floor. This innovative technology, a collaboration re...

Enhancing Cardiac Care: The Urgent Need for Accurate Vulnerable Plaque Detection in Cardiovascular Intervention   A recent study published in The Lancet on the PREVENT trial shows that for patients with vulnerable coronary plaques, even when the stenosis (narrowing) isn’t severe...

Recently, a research paper titled “An in vitro feasibility study of 355 nm laser atherectomy for the treatment of peripheral atherosclerotic lesions”, co-authored by the team of Dr. Jianming Guo from the Vascular Surgery Department of Xuanwu Hospital Capital Medical University ...

  Introduction to the Milestone   In early September 2024, a leading medical center in Chile achieved a significant milestone by introducing Vivolight Medical's revolutionary multimodality OCT (Optical Coherence Tomography) device—Cornaris P80—and successfully conducting the co...